Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Works in CNS Drugs, 2021, Vol 35, Issue 3
Results: 7
1
2
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
3
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
- Published in:
- CNS Drugs, 2021, v. 35, n. 3, p. 331, doi. 10.1007/s40263-021-00797-x
- By:
- Publication type:
- Article
4
Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study.
- Published in:
- CNS Drugs, 2021, v. 35, n. 3, p. 305, doi. 10.1007/s40263-021-00795-z
- By:
- Publication type:
- Article
6
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management.
- Published in:
- CNS Drugs, 2021, v. 35, n. 3, p. 283, doi. 10.1007/s40263-020-00790-w
- By:
- Publication type:
- Article